Browsing byAuthorO'Brien, BA

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 31  next >
Issue DateTitleAuthor(s)
1997-05-01Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouseO'Brien, BA; Harmon, BV; Cameron, DP; Allan, DJ
2008-08-01Association of SLC11A1 promoter polymorphisms with the incidence of autoimmune and inflammatory diseases: A meta-analysisO'Brien, BA; Archer, NS; Simpson, AM; Torpy, FR; Nassif, NT
1996-02-20Beta-cell apoptosis is responsible for the development of iddm in the multiple low-dose streptozotocin modelO'Brien, BA; Harmon, BV; Cameron, DP; Allan, DJ
2016-03-01The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulusLund, ME; To, J; O'Brien, BA; Donnelly, S
2002-01-01Clearance of apoptotic β-cells is reduced in neonatal autoimmune diabetes-prone ratsO'Brien, BA; Fieldus, WE; Field, CJ; Finegood, DT
2001-07-07Decreased apoptosis in the ileum and ileal peyer's patches: A feature after infection with rabbit enteropathogenic Escherichia coli O103Heczko, U; Carthy, CM; O'Brien, BA; Finlay, BB
2006-03-01A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouseO'Brien, BA; Geng, X; Orteu, CH; Huang, Y; Ghoreishi, M; Zhang, YQ; Bush, JA; Li, G; Finegood, DT; Dutz, JP
2019-01-01Ex vivo expansion of murine MSC impairs transcription factor-induced differentiation into pancreatic β-cellsGerace, D; Martiniello-Wilks, R; Habib, R; Ren, B; Nassif, NT; O'Brien, BA; Simpson, AM
2018-01-01EXPRESSION OF HUMAN PANCREATIC TRANSCRIPTION FACTORS IN THE LIVERS OF FRG MICERen, B; La, QT; O'Brien, BA; Nassif, NT; Tan, Y; Gerace, D; Martiniello-Wilks, R; Torpy, F; Dane, AP; Alexander, IE; Simpson, AM
2013-01-01Fasciola hepatica: The therapeutic potential of a worm secretomeRobinson, MW; Dalton, JP; O'Brien, BA; Donnelly, S
2015-11-01Gene therapy for diabetes: reversal of diabetes in the humanised FRG mouse modelSimpson, A; Ren, B; O'Brien, BA; Alexander, IE; Nassif, NT; Tan, Y; Martiniello-Wilks, R
2015-11-01GENE THERAPY FOR DIABETES: REVERSAL OF DIABETES IN THE HUMANISED FRG MOUSE MODEL.Simpson, A; Ren, B; O'Brien, BA; Alexander, IE; Nassif, NT; Tan, Y; Martiniello-Wilks, R
2015-06-06Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: Systematic review and meta-analysisArcher, NS; Nassif, NT; O'Brien, BA
2008-01-01Growth-promoting effect of Rh(D) antibody on human pancreatic islet cellsFeller, JM; Simpson, AM; Nelson, M; Swan, MA; O'Connell, PJ; Hawthorne, WJ; Tao, C; O'Brien, BA
2012-11-01A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPaseRobinson, MW; Alvarado, R; To, J; Hutchinson, AT; Dowdell, SN; Lund, M; Turnbull, L; Whitchurch, CB; O'Brien, BA; Dalton, JP; Donnelly, S
2017-01-01The immune modulatory peptide FhHDM-1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophagesAlvarado, R; To, J; Lund, ME; Pinar, A; Mansell, A; Robinson, MW; O'Brien, BA; Dalton, JP; Donnelly, S
2007-09-01Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapyRen, B; O'Brien, BA; Swan, MA; Koina, ME; Nassif, N; Wei, MQ; Simpson, AM
2013-01-01Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapyRen, B; O'Brien, BA; Byrne, MR; Ch'ng, E; Gatt, PN; Swan, MA; Nassif, NT; Wei, MQ; Gijsbers, R; Debyser, Z; Simpson, AM
2015-08-01MELLIGEN CELSS: AN INSULIN-SECRETING HUMAN LIVER CELL LINE WHICH IS RESISTANT TO CYTOKINE-INDUCED IMMUNE ATTACKLawandi, J; Tao, C; Ren, B; Williams, P; Ling, D; Swan, MA; Nassif, NT; Torpy, FR; O'Brien, BA; Simpson, AM
2000-05-01Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosisO'Brien, BA; Harmon, BV; Cameron, DP; Allan, DJ